Search

Author/Creator Yanuv, Ilan

1. Cardiorenal outcomes with dapagliflozin by baseline glucose‐lowering agents: Post hoc analyses from DECLARE‐TIMI 58. Issue 1 (22nd September 2020)

Authors:
Cahn, Avivit; Wiviott, Stephen D.; Mosenzon, Ofri; Murphy, Sabina A.; Goodrich, Erica L.; Yanuv, Ilan; Rozenberg, Aliza; Wilding, John P. H.; Leiter, Lawrence A.; Bhatt, Deepak L.; McGuire, Darren K.; Litwak, Leon; Kooy, Adriaan; Gause‐Nilsson, Ingrid A. M.; Fredriksson, Martin; Langkilde, Anna M...
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 23:Issue 1(2021)
Page Start:
29
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Cardiovascular and renal benefits of dapagliflozin in patients with short and long‐standing type 2 diabetes: Analysis from the DECLARE‐TIMI 58 trial. Issue 7 (12th March 2020)

Authors:
Bajaj, Harpreet S.; Raz, Itamar; Mosenzon, Ofri; Murphy, Sabina A.; Rozenberg, Aliza; Yanuv, Ilan; Bhatt, Deepak L.; Leiter, Lawrence A.; McGuire, Darren K.; Wilding, John P. H.; Gause‐Nilsson, Ingrid A. M.; Sabatine, Marc S.; Wiviott, Stephen D.; Cahn, Avivit
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 22:Issue 7(2020)
Page Start:
1122
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial. Issue 8 (August 2019)

Authors:
Mosenzon, Ofri; Wiviott, Stephen D; Cahn, Avivit; Rozenberg, Aliza; Yanuv, Ilan; Goodrich, Erica L; Murphy, Sabina A; Heerspink, Hiddo J L; Zelniker, Thomas A; Dwyer, Jamie P; Bhatt, Deepak L; Leiter, Lawrence A; McGuire, Darren K; Wilding, John P H; Kato, Eri T; Gause-Nilsson, Ingrid A M; Fredri...
Journal:
Lancet
Issue:
Volume 7:Issue 8(2019)
Page Start:
606
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial. Issue 4 (April 2023)

Authors:
Schechter, Meir; Wiviott, Stephen D; Raz, Itamar; Goodrich, Erica L; Rozenberg, Aliza; Yanuv, Ilan; Murphy, Sabina A; Zelniker, Thomas A; Fredriksson, Martin; Johansson, Peter A; Leiter, Lawrence A; Bhatt, Deepak L; McGuire, Darren K; Wilding, John P H; Gause-Nilsson, Ingrid A M; Cahn, Avivit; La...
Journal:
Lancet
Issue:
Volume 11:Issue 4(2023)
Page Start:
233
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR‐TIMI 53 outcome study. Issue 7 (8th March 2017)

Authors:
Cahn, Avivit; Mosenzon, Ofri; Bhatt, Deepak L.; Leibowitz, Gil; Yanuv, Ilan; Rozenberg, Aliza; Iqbal, Nayyar; Hirshberg, Boaz; Stahre, Christina; Im, KyungAh; Kanevsky, Estella; Raz, Itamar
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 19:Issue 7(2017)
Page Start:
1045
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE‐TIMI 58 study. Issue 8 (27th April 2020)

Authors:
Cahn, Avivit; Raz, Itamar; Bonaca, Marc; Mosenzon, Ofri; Murphy, Sabina A.; Yanuv, Ilan; Rozenberg, Aliza; Wilding, John P. H.; Bhatt, Deepak L.; McGuire, Darren K.; Gause‐Nilsson, Ingrid A. M.; Fredriksson, Martin; Johansson, Peter A.; Jermendy, Gyorgy; Hadjadj, Samy; Langkilde, Anna Maria; Saba...
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 22:Issue 8(2020)
Page Start:
1357
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗